Crux of drug compatibility and incompatibility

American Journal of Health-System Pharmacy

Volumn 67, Issue 2, 2010, Pages

  Newton, David W ^a  

^a SHENANDOAH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CEFTOBIPROLE MEDOCARIL; CLINDAMYCIN;

ACID BASE BALANCE; CHEMICAL STRUCTURE; DRUG INCOMPATIBILITY; DRUG MIXTURE; EXCIPIENT COMPATIBILITY; HUMAN; LETTER; PHARMACIST; PRIORITY JOURNAL; RELIABILITY;

EID: 75149112856     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090092     Document Type: Letter

References (6)

1. Newton DW. Drug incompatibility chemistry. Am J Health-Syst Pharm. 2009; 66:348-57. [Correction. Am J Health-Syst Pharm. 2009; 66:1431.]
2. Condie CK, Tyler LS, Barker B et al. Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery. Am J Health-Syst Pharm. 2008; 65:454-7. [Correction. Am J Health-Syst Pharm. 2008; 65:1597.]
3. Chan P, Bishop A, Kupiec TC, et al. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm. 2008; 65:1545-51.
4. Zeftera for injection product monograph. http://www.janssenortho.com/JOI/ pdf-fues/Zeftera-E.pdf (accessed March 30, 2009).
5. Nemec K, Kopelent-Frank H, Greif R. Standardization of infusion solutions to reduce the risk of incompatibility. Am J Health-Syst Pharm. 2008; 65:1648-54.
6. Trissel LA. Handbook on injectable drugs, 15th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2009.